Paola Grandi

Dr. Grandi brings to BryoLogyx over 15 years of immunotherapy experience in academia and industry. Her research and expertise include oncolytic viral vectors, cellular microRNAs, and onco-immunology.

After earning her PhD in Biochemistry from the University of Ferrara (Italy), Paula moved to the U.S. to pursue her interests in oncolytic Herpes Simplex Virus-based vectors. Her academic career started at Massachusetts General Hospital (Harvard Medical School) and subsequently at University of Pittsburgh School of Medicine. Her academic research produced the patent that provided the core technologies to founding an immuno-oncology venture, where she also served as its Director of Tumor Immunology Virology. Subsequently, Paula served as Chief Scientific Officer of a public oncology company and served as a consultant to various immuno-oncology and oncology companies.